文献速递血液净化与透析

累积透析葡萄糖暴露是使用中性pH透析液行腹膜透析的儿童患者腹膜纤维化和血管新生的危险因素

Cumulative Dialytic Glucose Exposure is a Risk Factor for Peritoneal Fibrosis and Angiogenesis in Pediatric Patients Undergoing Peritoneal Dialysis Using Neutral-pH Fluids.
PubMed 文献 · Kidney Int Rep · 2022-09-03

该研究比较了使用传统透析液(31例)与中性pH透析液(33例)的儿童腹膜透析患者,发现倾向评分匹配后传统组腹膜下致密带增厚更明显且管腔/血管直径比更低。在中性pH组中,累积透析葡萄糖暴露是腹膜下致密带厚度增加(OR 1.54,95%CI 1.16-2.05)和微血管密度增高(OR 1.29,95%CI 1.01-1.64)的独立危险因素,机制可能与HIF-1α和VEGF-α表达增加有关。

要点

  • 使用中性pH透析液的儿童腹膜透析患者中,累积透析葡萄糖暴露与腹膜纤维化和血管新生独立相关。
  • 传统透析液组较中性pH透析液组腹膜下致密带增厚更明显、管腔/血管直径比更低。
  • 高糖可增加人腹膜间皮细胞HIF-1α和VEGF-α表达,提示缺氧反应参与机制。

核心结论

  • 累积透析葡萄糖暴露是使用中性pH透析液的儿童腹膜透析患者腹膜纤维化和血管新生的独立危险因素,可能与肌成纤维细胞产生更多VEGF-α提示缺氧反应有关。

研究设计与样本

  • 比较使用传统透析液的儿童腹膜透析患者(传统组,n=31)与使用中性pH透析液者(中性pH组,n=33)的研究。
  • 采用广义线性模型分析中性pH组腹膜病理改变的临床危险因素,并通过免疫组化研究和培养细胞探索机制。
  • 总体患者透析时间中位数(四分位距)为3.2(1.7-5.3)年。

主要发现

  • 倾向评分匹配后,传统组腹膜下致密带增厚较中性pH组增加,管腔/血管直径比较中性pH组降低。
  • 中性pH组中,累积透析葡萄糖暴露是腹膜下致密带厚度增加(OR 1.54,95%CI 1.16-2.05)和腹膜下微血管密度增高(OR 1.29,95%CI 1.01-1.64)的独立危险因素。
  • 免疫组化研究显示累积透析葡萄糖暴露与组织表达HIF-1α和VEGF-α的比例相关。
  • 人腹膜间皮细胞中,高糖显著增加HIF-1α和VEGF-α表达。

关键数值与推荐

  • 中性pH组累积透析葡萄糖暴露对腹膜下致密带厚度增加的OR为1.54(95%CI 1.16-2.05)。
  • 中性pH组累积透析葡萄糖暴露对腹膜下微血管密度增高的OR为1.29(95%CI 1.01-1.64)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Neutral-pH dialysate has been reported to be beneficial to prevent the peritoneal pathological changes in adult peritoneal dialysis (PD) patients, but its use is controversial in pediatric PD patients. In addition, the impact of cumulative dialytic glucose exposure has not been examined. METHODS: Pediatric PD patients using conventional fluids (conventional group, n = 31) or those using neutral-pH fluids (neutral-pH group, n = 33) were compared. Clinical risk factors for peritoneal pathological changes in the neutral-pH group were analyzed using generalized linear modeling. Furthermore, the mechanisms of peritoneal pathological changes were explored using immunohistochemical studies and cultured cells. RESULTS: The median (interquartile range) duration of dialysis was 3.2 (1.7-5.3) years in overall patients. After propensity score matching, the conventional group showed increased thickening of the submesothelial compact (SMC) zone and lower luminal-to-vessel diameter (L/V) ratio than the neutral-pH group. In the neutral-pH group, the cumulative dialytic glucose exposure was an independent risk factor for greater thickness of the SMC zone (odds ratio [OR], 1.54; 95% confidence interval [CI], 1.16-2.05) and higher submesothelial microvessel density (OR, 1.29; 95% CI, 1.01-1.64). Immunohistochemical study showed that cumulative dialytic glucose exposure correlated with the proportion of the tissue expressing hypoxia inducible factor -1α (HIF-1α) and vascular endothelial growth factor-α (VEGF-α). In human peritoneal mesothelial cells, high glucose significantly increased HIF-1α and VEGF-α expressions. CONCLUSION: Cumulative dialytic glucose exposure is an independent risk factor for peritoneal fibrosis and angiogenesis in pediatric patients undergoing PD using neutral-pH fluids, which might be associated with greater VEGF-α production by myofibroblasts implying a hypoxic response.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Shirai Y, Miura K, Ike T, et al. Cumulative Dialytic Glucose Exposure is a Risk Factor for Peritoneal Fibrosis and Angiogenesis in Pediatric Patients Undergoing Peritoneal Dialysis Using Neutral-pH Fluids. Kidney Int Rep. 2022. PMID: 36531887. doi:10.1016/j.ekir.2022.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。